The von Willebrand Factor antigen to platelet ratio (VITRO) score predicts hepatic decompensation and mortality in cirrhosis
ConclusionsVITRO is a valuable prognostic tool for estimating the risk of decompensation and mortality in patients with compensated cirrhosis —including the setting after hepatitis C eradication.
Source: Journal of Gastroenterology - Category: Gastroenterology Source Type: research
More News: Bleeding | Children | Cirrhosis | Gastroenterology | Hepatitis | Hepatitis C | Hypertension | Liver | Liver Transplant | Study | Transplant Surgery | Transplants | Urology & Nephrology | von Willebrand Disease